Your search resulted in multiple matches. Please select a position:

Gencode Genes

ACLY (ENST00000590151.5) at chr17:41866917-41918962 - Homo sapiens ATP citrate lyase (ACLY), transcript variant 3, mRNA. (from RefSeq NM_001303274)
ACLY (ENST00000592970.1) at chr17:41910239-41930542 - ATP citrate lyase (from HGNC ACLY)
ACLY (ENST00000590770.5) at chr17:41897801-41918951 - ATP citrate lyase (from HGNC ACLY)
ACLY (ENST00000590735.1) at chr17:41906598-41918951 - ATP citrate lyase (from HGNC ACLY)
ACLY (ENST00000588779.1) at chr17:41867761-41870719 - ATP citrate lyase (from HGNC ACLY)
ACLY (ENST00000588547.1) at chr17:41904440-41905641 - ATP citrate lyase (from HGNC ACLY)
ACLY (ENST00000537919.5) at chr17:41867456-41918983 - ATP citrate-lyase is the primary enzyme responsible for  the synthesis of cytosolic acetyl-CoA in many tissues. Has a  central role in de novo lipid synthesis. In nervous tissue it may  be involved in the biosynthesis of acetylcholine. (from UniProt P53396)
ACLY (ENST00000393896.6) at chr17:41867574-41919022 - ATP citrate-lyase is the primary enzyme responsible for  the synthesis of cytosolic acetyl-CoA in many tissues. Has a  central role in de novo lipid synthesis. In nervous tissue it may  be involved in the biosynthesis of acetylcholine. (from UniProt P53396)
ACLY (ENST00000353196.5) at chr17:41866931-41919019 - Homo sapiens ATP citrate lyase (ACLY), transcript variant 2, mRNA. (from RefSeq NM_198830)
ACLY (ENST00000352035.7) at chr17:41866918-41918951 - Homo sapiens ATP citrate lyase (ACLY), transcript variant 1, mRNA. (from RefSeq NM_001096)
AKT1 (ENST00000649815.1) at chr14:104769371-104795555 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT1 (ENST00000554848.5) at chr14:104770341-104794191 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT1 (ENST00000554581.5) at chr14:104769349-104794124 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT1 (ENST00000402615.6) at chr14:104769352-104794528 - AKT1 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. Phosphorylates  STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its:  kinase activity, nuclear translocation, autophosphorylation and  ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-  117' and 'Thr-384' leading to inhibition of its: cleavage, kinase  activity, autophosphorylation at Thr-180, binding to RASSF1 and  nuclear translocation. Phosphorylates SRPK2 and enhances its  kinase activity towards SRSF2 and ACIN1 and promotes its nuclear  translocation. Phosphorylates RAF1 at 'Ser-259' and negatively  regulates its activity. Phosphorylation of BAD stimulates its pro-  apoptotic activity. (from UniProt P31749)
AKT2 (ENST00000311278.10) at chr19:40233841-40265312 - AKT2 is one of 3 closely related serine/threonine-  protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and  which regulate many processes including metabolism, proliferation,  cell survival, growth and angiogenesis. This is mediated through  serine and/or threonine phosphorylation of a range of downstream  substrates. Over 100 substrate candidates have been reported so  far, but for most of them, no isoform specificity has been  reported. AKT is responsible of the regulation of glucose uptake  by mediating insulin-induced translocation of the SLC2A4/GLUT4  glucose transporter to the cell surface. Phosphorylation of PTPN1  at 'Ser-50' negatively modulates its phosphatase activity  preventing dephosphorylation of the insulin receptor and the  attenuation of insulin signaling. Phosphorylation of TBC1D4  triggers the binding of this effector to inhibitory 14-3-3  proteins, which is required for insulin-stimulated glucose  transport. AKT regulates also the storage of glucose in the form  of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at  'Ser-9', resulting in inhibition of its kinase activity.  Phosphorylation of GSK3 isoforms by AKT is also thought to be one  mechanism by which cell proliferation is driven. AKT regulates  also cell survival via the phosphorylation of MAP3K5 (apoptosis  signal-related kinase). Phosphorylation of 'Ser-83' decreases  MAP3K5 kinase activity stimulated by oxidative stress and thereby  prevents apoptosis. AKT mediates insulin-stimulated protein  synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462',  thereby activating mTORC1 signaling and leading to both  phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is  involved in the phosphorylation of members of the FOXO factors  (Forkhead family of transcription factors), leading to binding of  14-3-3 proteins and cytoplasmic localization. In particular, FOXO1  is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and  FOXO4 are phosphorylated on equivalent sites. AKT has an important  role in the regulation of NF-kappa-B-dependent gene transcription  and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-  response element binding protein). The phosphorylation of CREB1  induces the binding of accessory proteins that are necessary for  the transcription of pro-survival genes such as BCL2 and MCL1. AKT  phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby  potentially regulating ACLY activity and fatty acid synthesis.  Activates the 3B isoform of cyclic nucleotide phosphodiesterase  (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced  cyclic AMP levels and inhibition of lipolysis. Phosphorylates  PIKFYVE on 'Ser-318', which results in increased PI(3)P-5  activity. The Rho GTPase-activating protein DLC1 is another  substrate and its phosphorylation is implicated in the regulation  cell proliferation and cell growth. AKT plays a role as key  modulator of the AKT-mTOR signaling pathway controlling the tempo  of the process of newborn neurons integration during adult  neurogenesis, including correct neuron positioning, dendritic  development and synapse formation. Signals downstream of  phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of  various growth factors such as platelet-derived growth factor  (PDGF), epidermal growth factor (EGF), insulin and insulin-like  growth factor I (IGF-I). AKT mediates the antiapoptotic effects of  IGF-I. Essential for the SPATA13-mediated regulation of cell  migration and adhesion assembly and disassembly. May be involved  in the regulation of the placental development. (from UniProt P31751)
AKT2 (ENST00000392038.7) at chr19:40230317-40285345 - Homo sapiens AKT serine/threonine kinase 2 (AKT2), transcript variant 1, mRNA. (from RefSeq NM_001626)
AKT1 (ENST00000555528.5) at chr14:104769371-104793700 - Homo sapiens AKT serine/threonine kinase 1 (AKT1), transcript variant 1, mRNA. (from RefSeq NM_005163)
AKT1 (ENST00000349310.7) at chr14:104769349-104795751 - Homo sapiens AKT serine/threonine kinase 1 (AKT1), transcript variant 2, mRNA. (from RefSeq NM_001014432)
AKT1 (ENST00000407796.6) at chr14:104769349-104795679 - Homo sapiens AKT serine/threonine kinase 1 (AKT1), transcript variant 3, mRNA. (from RefSeq NM_001014431)
AKT2 (ENST00000424901.5) at chr19:40230318-40285395 - Homo sapiens AKT serine/threonine kinase 2 (AKT2), transcript variant 4, mRNA. (from RefSeq NM_001330511)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_001303274.1 at chr17:41866917-41919022
NM_001303275.1 at chr17:41866917-41919022
NM_001096.3 at chr17:41866918-41918951
NM_198830.1 at chr17:41866926-41919019

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_005257395.1 at chr17:41866916-41930542
XM_017024688.1 at chr17:41866916-41930542

NCBI RefSeq and Ensembl transcripts from the MANE Project (v0.6)

ACLY at chr17:41866918-41918951

RefSeq Genes

ACLY at chr17:41866917-41919022 - (NM_001303275) ATP-citrate synthase isoform 4
ACLY at chr17:41866917-41919022 - (NM_001303274) ATP-citrate synthase isoform 3
ACLY at chr17:41866926-41919019 - (NM_198830) ATP-citrate synthase isoform 2
ACLY at chr17:41866918-41918951 - (NM_001096) ATP-citrate synthase isoform 1

Non-Human RefSeq Genes

ACLY at chr17:41866965-41913899 - (NM_001257276) ATP-citrate synthase isoform 1
ACLY at chr17:41866933-41919018 - (NM_001105302) ATP-citrate synthase isoform 2
acly at chr17:41867810-41913873 - (NM_001008027) ATP-citrate synthase
ACLY at chr17:41867804-41913886 - (NM_001030540) ATP-citrate synthase
ACLY at chr17:41866923-41913909 - (NM_001037457) ATP-citrate synthase
Acly at chr17:41866957-41918974 - (NM_016987) ATP-citrate synthase isoform 1
Acly at chr17:41866957-41918974 - (NM_001111095) ATP-citrate synthase isoform 2
Acly at chr17:41866954-41919075 - (NM_001199296) ATP-citrate synthase isoform 1
Acly at chr17:41866954-41919075 - (NM_134037) ATP-citrate synthase isoform 2
ACLY at chr17:41867810-41913873 - (NM_001038622) ATP-citrate synthase
acly-1 at chr17:41867825-41913873 - (NM_075879) Probable ATP-citrate synthase
acly-2 at chr17:41867825-41912536 - (NM_073866) ATP-citrate synthase
acly.S at chr17:41867810-41913873 - (NM_001094786) ATP citrate lyase S homeolog
aclya at chr17:41867810-41913873 - (NM_001002649) ATP-citrate synthase

Basic Gene Annotation Set from GENCODE Version 33 (Ensembl 99)

ACLY at chr17:41866917-41918962
ACLY at chr17:41866918-41918951
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 33 (Ensembl 99)

ACLY at chr17:41866917-41918962
ACLY at chr17:41866918-41918951
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

ACLY at chr17:41866917-41918962
ACLY at chr17:41866918-41918951
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

ACLY at chr17:41866917-41918962
ACLY at chr17:41866918-41918951
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

ACLY at chr17:41866908-41918987
ACLY at chr17:41866917-41918962
ACLY at chr17:41866931-41919019
ACLY at chr17:41867456-41918983
ACLY at chr17:41867574-41919022
ACLY at chr17:41867761-41870719
ACLY at chr17:41897801-41918951
ACLY at chr17:41904440-41905641
ACLY at chr17:41906598-41918951
ACLY at chr17:41910239-41930542

International Knockout Mouse Consortium Genes Mapped to Human Genome

Acly_46256 at chr17:41866926-41919019
Acly_80097 at chr17:41866926-41919019
Acly_VG15640 at chr17:41866926-41919019

Human Aligned mRNA Search Results

AB210035 - Homo sapiens mRNA for ACLY variant protein, partial cds, clone: hk02197.
BC006195 - Homo sapiens ATP citrate lyase, mRNA (cDNA clone MGC:1812 IMAGE:2959339), complete cds.

Non-Human Aligned mRNA Search Results

BC080908 - Xenopus tropicalis acly protein, mRNA (cDNA clone MGC:79528 IMAGE:6977798), complete cds.
BC005533 - Mus musculus ATP citrate lyase, mRNA (cDNA clone IMAGE:3496817), partial cds.
BC065805 - Mus musculus ATP citrate lyase, mRNA (cDNA clone IMAGE:1398077), complete cds.
BC100618 - Rattus norvegicus ATP citrate lyase, mRNA (cDNA clone MGC:124629 IMAGE:7934668), complete cds.
BC021502 - Synthetic construct Mus musculus ATP citrate lyase, mRNA (cDNA clone IMAGE:5346507), partial cds.
AB706398 - Ursus thibetanus japonicus LCAD mRNA for long chain acly-CoA dehydrogenase, partial cds.
KX671161 - Paracyclopina nana ACLY mRNA, complete cds.
BC056378 - Mus musculus ATP citrate lyase, mRNA (cDNA clone MGC:73502 IMAGE:6850252), complete cds.
EU107795 - Phodopus sungorus ATP citrate lyase (Acly) mRNA, partial cds.
JT414132 - TSA: Ictalurus punctatus aby_k37:1772538 mRNA sequence.
BC076484 - Danio rerio ATP citrate lyase, mRNA (cDNA clone MGC:92008 IMAGE:7043656), complete cds.
EU441639 - Xenopus borealis clone Acly.a ATP citrate lyase alpha (ACLYalpha) mRNA, partial cds.
EU441283 - Xenopus borealis clone Acly.b ATP citrate lyase beta (ACLYbeta) mRNA, partial cds.
DQ147961 - Macaca mulatta clone dl2_l03_t7_080 ATP citrate lyase (ACLY) mRNA, partial cds.
JQ087331 - Sus scrofa ATP citrate lyase long isoform (ACLY) mRNA, complete cds.
JQ087332 - Sus scrofa ATP citrate lyase short isoform (ACLY) mRNA, complete cds.
AY971952 - Ovis aries ATP-citrate lyase (ACLY) mRNA, complete cds.
BC108138 - Bos taurus ATP citrate lyase, mRNA (cDNA clone MGC:128987 IMAGE:8120874), complete cds.
JU334639 - TSA: Macaca mulatta Mamu_509808 mRNA sequence.
JU334640 - TSA: Macaca mulatta Mamu_509809 mRNA sequence.
JU475699 - TSA: Macaca mulatta Mamu_375024 mRNA sequence.
JV044005 - TSA: Macaca mulatta Mamu_411471 mRNA sequence.
HM173531 - Anser anser anser ATP-citrate lyase (ACLY) mRNA, complete cds.
AM883107 - Anas platyrhynchos partial putative acly mRNA.
AM883106 - Cairina moschata partial putative acly mRNA.
JQ790256 - Asterocampa celtis voucher Acly glu-/pro-tRNA synthetase mRNA, partial cds.
JQ789858 - Asterocampa celtis voucher Acly acetyl-coA carboxylase mRNA, partial cds.
JQ788977 - Asterocampa celtis voucher Acly AMP deaminase mRNA, partial cds.
JQ788680 - Asterocampa celtis voucher Acly tetrahydrofolate synthase mRNA, partial cds.
JQ788433 - Asterocampa celtis voucher Acly GTP-binding protein mRNA, partial cds.
JQ787675 - Asterocampa celtis voucher Acly gelsolin mRNA, partial cds.
JQ787389 - Asterocampa celtis voucher Acly nucleolar cysteine-rich protein mRNA, partial cds.
JQ787099 - Asterocampa celtis voucher Acly phosphogluconate dehydrogenase mRNA, partial cds.
JQ786233 - Asterocampa celtis voucher Acly glucose phosphate dehydrogenase mRNA, partial cds.
JQ783955 - Asterocampa celtis voucher Acly triosephosphate isomerase mRNA, partial cds.
EU033050 - Asterocampa clyton voucher Acly putative wingless protein mRNA, partial cds.
EU032891 - Asterocampa clyton voucher Acly putative enolase protein mRNA, partial cds.
EU032769 - Asterocampa clyton voucher Acly putative dopa decarboxylase protein mRNA, partial cds.
EU032632 - Asterocampa clyton voucher Acly putative CAD trifunctional protein mRNA, partial cds.
EU032633 - Asterocampa clyton voucher Acly putative CAD trifunctional protein mRNA, partial cds.
EU032634 - Asterocampa clyton voucher Acly putative CAD trifunctional protein mRNA, partial cds.